Futura Medical (LON:FUM) announced its quarterly earnings results on Wednesday. The company reported GBX (0.44) (($0.01)) EPS for the quarter, Digital Look Earnings reports.
Shares of LON:FUM traded down GBX 0.25 ($0.00) during midday trading on Wednesday, reaching GBX 17.25 ($0.23). The company had a trading volume of 188,894 shares, compared to its average volume of 960,258. Futura Medical has a 52-week low of GBX 7.16 ($0.09) and a 52-week high of GBX 36 ($0.47). The company’s 50 day moving average price is GBX 16.26 and its 200 day moving average price is GBX 14.36. The stock has a market cap of $42.37 million and a P/E ratio of -3.92.
Separately, Liberum Capital reaffirmed a “buy” rating on shares of Futura Medical in a report on Tuesday, July 14th.
Futura Medical plc develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom.
Further Reading: Stocks Increasing Dividends
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.